Hans Mallmin

4PUBLICATIONS
9CO-AUTHORS
EndodonticsHaematologyHaematological tumoursEquity and trusts law
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Apr 01, 2026
Denosumab and bone loss in uncemented total hip arthroplasty: a secondary 5-year follow-up of a randomized controlled trial.

Caroline Sköld, Nils P Hailer, Hans Mallmin

|May 24, 2022
Effects of denosumab treatment on the expression of receptor activator of nuclear kappa-B ligand (RANKL) and TNF-receptor TNFRSF9 after total hip arthroplasty-results from a randomized placebo-controlled clinical trial.

C Sköld, K Kultima, E Freyhult

|Jan 03, 2020
Safety of Use of Tantalum in Total Hip Arthroplasty.

Anders Brüggemann, Hans Mallmin, Mats Bengtsson

|Dec 22, 2018
Haplotypes in the CYP2R1 gene are associated with levels of 25(OH)D and bone mineral density, but not with other markers of bone metabolism (MrOS Sweden).

Anne Björk, Dan Mellström, Claes Ohlsson

Pageof 1

Frequent Collaborators

3 joint publications

Nils P Hailer

1 joint publications

C Sköld

1 joint publications

K Kultima

1 joint publications

E Freyhult